Methylation of dietary flavones increases their metabolic stability and chemopreventive effects

International Journal of Molecular Sciences

Volumn 10, Issue 11, 2009, Pages 5002-5019

  Walle, Thomas ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Cancer prevention; Flavonoids; Methoxyflavones; Methylation

Indexed keywords

3',4' DIMETHOXYFLAVONE; 5,7 DIMETHOXYFLAVONE; 5,7,4' TRIMETHOXYFLAVONE; APIGENIN; APIGENIN DERIVATIVE; AROMATASE; CHRYSIN; FLAVONE DERIVATIVE; TRICIN; UNCLASSIFIED DRUG;

CANCER PREVENTION; CHEMOPROPHYLAXIS; DRUG EFFECT; DRUG POTENCY; HUMAN; MEMBRANE TRANSPORT; METHYLATION; NONHUMAN; REACTION ANALYSIS; REVIEW;

CANCER PREVENTION; FLAVONOIDS; METHOXYFLAVONES; METHYLATION;

ANIMALS; CELL MEMBRANE PERMEABILITY; DIET; FLAVONES; HALF-LIFE; HUMANS; METHYLATION; MICROSOMES, LIVER; NEOPLASMS;

EID: 71649098481     PISSN: None     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms10115002     Document Type: Review

References (81)

1. Middleton, E.J.; Kandaswami, C.; Theoharides, T.C. The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52, 673-751.
2. Williams, R.J.; Spencer, J.P.E.; Rice-Evans, C. Flavonoids: Antioxidants and signalling molecules? Free Radic. Biol. Med. 2004, 36, 838-849.
3. Doostdar, H.; Burke, M.D.; Mayer, R.T. Bioflavonoids: Selective substrates and inhibitors for cytochrome P450 CYP1A and CYP1B1. Toxicology 2000, 144, 31-38.
4. Guengerich, F.P.; Chun, Y.-J.; Kim, D.; Gillam, E.M.J.; Shimada, T. Cytochrome P450 1B1: A target for inhibition in anticarcinogenesis strategies. Mut. Res. 2003, 523-524, 173-182. (Pubitemid 36293244)
5. Wen, X.; Walle, T. Preferential induction of CYP1B1 by benzo[a]pyrene in human oral epithelial cells: Impact on DNA adduct formation and prevention by polyphenols. Carcinogenesis 2005, 26, 1774-1781. (Pubitemid 41487994)
6. Wen, X.; Walle, U.K.; Walle, T. 5,7-Dimethoxyflavone down-regulates CYP1A1 expression and benzo[a]pyrene-induced DNA binding in Hep G2 cells. Carcinogenesis 2005, 26, 803-809. (Pubitemid 41214343)
7. Ciolino, H.P.; Daschner, P.J.; Yeh, G.C. Dietary flavonols quercetin and kaempferol are ligands of the aryl hydrocarbon receptor that affect CYP1A1 transcription differentially. Biochem. J. 1999, 340, 715-722.
8. Tsuji, P.A.; Walle, T. Inhibition of benzo[a]pyrene-activating enzymes and DNA-binding in human bronchial epithelial BEAS-2B cells by methoxylated flavonoids. Carcinogenesis 2006, 27, 1579-1585. (Pubitemid 44288046)
9. Galijatovic, A.; Otake, Y.; Walle, U.K.; Walle, T. Induction of UDP-glucuronosyltransferase UGT1A1 by the flavonoid chrysin in Caco-2 cells-Potential role in carcinogen bioinactivation. Pharm. Res. 2001, 18, 374-379. (Pubitemid 32595827)
10. Gross-Steinmeyer, K.; Stapleton, P.L.; Liu, F.; Tracy, J.H.; Bammler, T.K.; Quigley, S.D.; Farin, F.M.; Buhler, D.R.; Safe, S.H.; Strom, S.C.; Eaton, D.L. Phytochemical-induced changes in gene expression of carcinogen-metabolizing enzymes in cultured human primary hepatocytes. Xenobiotica 2004, 34, 619-632. (Pubitemid 39486044)
11. Chou, F.P.; Chu, Y.C.; Hsu, J.D.; Chiang, H.C.; Wang, C.J. Specific induction of glutathione Stransferase GSTM2 subunit expression by epigallocatechin gallate in rat liver. Biochem. Pharmacol. 2000, 60, 643-650.
12. Fang, J.; Xia, C.; Cao, Z.; Zheng, J.Z.; Reed, E.; Jiang, B.-H. Apigenin inhibits VEGF and HIF-1 expression via PI3K/AKT/p70S6K1 and HDM2/p53 pathways. FASEB J. 2005, 19, 342-353.
13. Choi, H.; Chun, Y.-S.; Kim, S.-W.; Kim, M.-S.; Park, J.-W. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear translocator: A mechanism of tumor growth inhibition. Mol. Pharmacol. 2006, 70, 1664-1671.
14. Hou, Z.; Sang, S.; You, H.; Lee, M.-J.; Hong, J.; Chin, K.-V.; Yang, C.S. Mechanism of action of (-)-epigallocatechin-3-gallate: Auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells. Cancer Res. 2005, 65, 8049-8056.
15. Lu, J.; Papp, L.V.; Fang, J.; Rodriguez-Nieto, S.; Zhivotovsky, B.; Holmgren, A. Inhibition of mammalian thioredoxin reductase by some flavonoids: Implications for myricetin and quercetin anticancer activity. Cancer Res. 2006, 66, 4410-4418.
16. Haghiac, M.; Walle, T. Quercetin induces necrosis and apoptosis in the SCC-9 oral cancer cells. Nutr. Cancer 2005, 53, 220-231.
17. Ermakova, S.P.; Kang, B.S.; Choi, B.Y.; Choi, H.S.; Schuster, T.F.; Ma, W.-Y.; Bode, A.M.; Dong, Z. (-)-Epigallocatechin gallate overcomes resistance to etoposide-induced cell death by targeting the molecular chaperone glucose-regulated protein 78. Cancer Res. 2006, 66, 9260-9268.
18. Day, A.J.; DuPont, M.S.; Ridley, S.; Rhodes, M.; Rhodes, M.J.C.; Morgan, M.R.A.; Williamson, G. Deglycosylation of flavonoid and isoflavonoid glycosides by human small intestine and liver β- glucosidase activity. FEBS Lett. 1998, 436, 71-75. (Pubitemid 28454609)
19. Day, A.J.; Cañada, F.J.; Diaz, J.C.; Kroon, P.A.; Mclauchlan, R.; Faulds, C.B.; Plumb, G.W.; Morgan, M.R.A.; Williamson, G. Dietary flavonoid and isoflavone glycosides are hydrolysed by the lactase site of lactase phlorizin hydrolase. FEBS Lett. 2000, 468, 166-170. (Pubitemid 30110789)
20. Graefe, E.U.; Wittig, J.; Mueller, S.; Riethling, A.-K.; Uehleke, B.; Drewelow, B.; Pforte, H.; Jacobasch, G.; Derendorf, H.; Veit, M. Pharmacokinetics and bioavailability of quercetin glycosides in humans. J. Clin. Pharmacol. 2001, 41, 492-499.
21. Walle, T. Absorption and metabolism of flavonoids. Free Rad. Biol. Med. 2004, 36, 829-837.
22. Walle, T.; Browning, A.M.; Steed, L.S.; Reed, S.G.; Walle, U.K. Flavonoid glucosides are hydrolyzed and thus activated in the oral cavity in humans. J. Nutr. 2005, 135, 48-52.
23. Manach, C.; Donovan, J.L. Pharmacokinetics and metabolism of dietary flavonoids in humans. Free Rad. Res. 2004, 38, 771-785.
24. Williamson, G.; Manach, C. Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies. Am. J. Clin. Nutr. 2005, 81, 243S-255S.
25. Walle, T.; Otake, Y.; Brubaker, J.A.; Walle, U.K.; Halushka, P.V. Disposition and metabolism of the flavonoid chrysin in normal volunteers. Br. J. Clin. Pharmacol. 2001, 51, 143-146.
26. Goldberg, D.M.; Yan, J.; Soleas, G.J. Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin. Biochem. 2003, 36, 79-87.
27. Walle, T.; Hsieh, F.; DeLegge, M.H.; Oatis, J.E.J.; Walle, U.K. High absorption but very low bioavailability of oral resveratrol in humans. Drug Metab. Dispos. 2004, 32, 1377-1382.
28. Walle, T.; Walle, U.K.; Halushka, P.V. Carbon dioxide is the major metabolite of quercetin in humans. J. Nutr. 2001, 131, 2648-2652.
29. Chow, H.H.S.; Cai, Y.; Alberts, D.S.; Hakim, I.; Dorr, R.; Shahi, F.; Crowell, J.A.; Yang, C.S.; Hara, Y. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenol E. Cancer Epidemiol. Biomarkers Prev. 2001, 10, 53-58. (Pubitemid 32106044)
30. Warden, B.A.; Smith, L.S.; Beecher, G.R.; Balentine, D.A.; Clevidence, B.A. Catechins are bioavailable in men and women drinking black tea throughout the day. J. Nutr. 2001, 131, 1731-1737.
31. Hong, J.; Lambert, J.D.; Lee, S.-H.; Sinko, P.J.; Yang, C.S. Involvement of multidrug resistanceassociated proteins in regulating cellular levels of (-)-epigallocatechin-3-gallate and its methyl metabolites. Biochem. Biophys. Res. Commun. 2003, 310, 222-227.
32. Vaidyanathan, J.B.; Walle, T. Cellular uptake of the anticancer tea flavonoid (-)-epicatechin-3- gallate (ECG) by an apical membrane transporter in Caco-2 cells. In AAPS Annual Meeting, Toronto, Canada, 2002.
33. Walton, M.C.; McGhie, T.K.; Reynolds, G.W.; Hendriks, W.H. The flavonol quercetin-3-glucoside inhibits cyanidin-3-glucoside absorption in vitro. J. Agric. Food Chem. 2006, 54, 4913-4920.
34. Duarte Silva, I.; Rodrigues, A.S.; Gaspar, J.; Laires, A.; Rueff, J. Metabolism of galangin by rat cytochromes P450: Relevance to the genotoxicity of galangin. Mutation Res. 1997, 393, 247-257. (Pubitemid 27481051)
35. Nielsen, S.E.; Breinholt, V.; Justesen, U.; Cornett, C.; Dragsted, L.O. In vitro biotransformation of flavonoids by rat liver microsomes. Xenobiotica 1998, 28, 389-401. (Pubitemid 28207043)
36. Otake, Y.; Walle, T. Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9. Drug Metab. Dispos. 2002, 30, 103-105. (Pubitemid 34106526)
37. Otake, Y.; Hsieh, F.; Walle, T. Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes. Drug Metab. Dispos. 2002, 30, 576-581. (Pubitemid 34456981)
38. Breinholt, V.M.; Rasmussen, S.E.; Brøsen, K.; Friedberg, T.H. In vitro metabolism of genistein and tangeretin by human and murine cytochrome P450s. Pharmacol. Toxicol. 2003, 93, 14-22. (Pubitemid 36819369)
39. Hu, M.; Krausz, K.; Chen, J.; Ge, X.; Li, J.; Gelboin, H.L.; Gonzalez, F.J. Identification of CYP1A2 as the main isoform for the phase I hydroxylated metabolism of genistein and a prodrug converting enzyme of methylated isoflavones. Drug Metab. Dispos. 2003, 31, 924-931.
40. Lu, Y.; Zhang, C.; Bucheli, P.; Wei, D. Citrus flavonoids in fruit and traditional Chinese medicinal food ingredients in China. Plant Foods Hum. Nutr. 2006, 61, 57-65. (Pubitemid 44091199)
41. Nogata, Y.; Sakamoto, K.; Shiratsuchi, H.; Ishii, T.; Yano, M.; Ohta, H. Flavonoid composition of fruit tissues of citrus species. Biosci. Biotechnol. Biochem. 2006, 70, 178-192. (Pubitemid 43150976)
42. Mizuno, M.; Iinuma, M.; Ohara, M.; Tanaka, T.; Iwamasa, M. Chemotaxonomy of the genus Citrus based on polymethoxyflavones. Chem. Pharm. Bull. 1991, 39, 945-949.
43. Jaipetch, T.; Reutrakul, V.; Tuntiwachwuttikul, P.; Santisuk, T. Flavonoids in the black rhizomes of Boesenbergia pandurata. Phytochemistry 1983, 22, 625-626.
44. Yenjai, C.; Prasanphen, K.; Daodee, S.; Wongpanich, V.; Kittakoop, P. Bioactive flavonoids from Kaempferia parviflora. Fitoterapia 2004, 75, 89-92.
45. Cavalcante, S.H.; Fernandes, D.; Paulino Fo, H.F.; Yoshida, M.; Gottlieb, O.R. Lignoids from the fruit of three Virola species. Phytochemistry 1985, 24, 1865-1866.
46. Santos, L.S.; Corréa, M.J.C.; Campos, L.M.O.; Andrade, M.A. Constituents from the leaves of Virola michelli. Fitoterapia 1996, 67, 555-556.
47. Ahmad, F.; Bakar, S.A.; Ibrahim, A.Z.; Read, R.W. Constituents of the leaves of Piper caninum. Planta Med. 1997, 63, 193-194.
48. Walle, T. Methylation of dietary flavones greatly improves their hepatic metabolic stability and intestinal absorption. Mol. Pharmaceut. 2007, 4, 826-832.
49. Walle, T. Methoxylated flavones, a superior cancer chemopreventive flavonoid subclass? Sem. Cancer Biol. 2007, 17, 354-362. (Pubitemid 47369171)
50. Walle, T.; Wen, X.; Walle, U.K. Improving metabolic stability of cancer chemopreventive polyphenols. Expert Opin. Drug Metab. Toxicol. 2007, 3, 379-388.
51. Wen, X.; Walle, T. Methylated flavonoids have greatly improved intestinal absorption and metabolic stability. Drug Metab. Dispos. 2006, 34, 1786-1792. (Pubitemid 44427483)
52. Artursson, P.; Karlsson, J. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 1991, 175, 880-885.
53. Walle, T.; Walgren, R.A.; Walle, U.K.; Galijatovic, A.; Vaidyanathan, J.B. Understanding the bioavailability of flavonoids through studies in Caco-2 cells. In Flavonoids in Health and Disease; Rice-Evans, C.A., Packer, L., Eds.; Marcel Dekker, Inc.: New York, NY, USA, 2003; pp. 349- 361.
54. Walle, T.; Ta, N.; Kawamori, T.; Wen, X.; Tsuji, P.A.; Walle, U.K. Cancer chemopreventive properties of orally bioavailable flavonoids-Methylated versus unmethylated flavones. Biochem. Pharmacol. 2007, 73, 1288-1296.
55. Walle, U.K.; Walle, T. Bioavailable flavonoids: Cytochrome P450-mediated metabolism of methoxyflavones. Drug Metab. Dispos. in press.
56. Manthey, J.A.; Guthrie, N.; Grohmann, K. Biological properties of citrus flavonoids pertaining to cancer and inflammation. Curr. Med. Chem. 2001, 8, 135-153. (Pubitemid 32421562)
57. Manthey, J.A.; Guthrie, N. Antiproliferative activities of citrus flavonoids against six human cancer cell lines. J. Agric. Food Chem. 2002, 50, 5837-5843. (Pubitemid 35155302)
58. Chiang, L.-C.; Ng, L.T.; Lin, I.-C.; Kuo, P.-L.; Lin, C.-C. Anti-proliferative effect of apigenin and its apoptotic induction in Hep G2 cells. Cancer Lett. 2006, 237, 207-214. (Pubitemid 43777073)
59. Trochon, V.; Blot, E.; Cymbalista, F.; Engelmann, C.; Tang, R.P.; Thomaidis, A.; Vasse, M.; Soria, J.; Lu, H.; Soria, C. Apigenin inhibits endothelial-cell proliferation in G(2)/M phase whereas it stimulates smooth-muscle cells by inhibiting P21 and P27 expression. Int. J. Cancer 2000, 85, 691-696. (Pubitemid 30080483)
60. Ujiki, M.B.; Ding, X.-Z.; Salabat, M.R.; Bentrem, D.J.; Golkar, L.; Milam, B.; Talamonti, M.S.; Bell, R.H.J.; Iwamura, T.; Adrian, T.E. Apigenin inhibits pancreatic cancer cell proliferation through G2/M cell cycle arrest. Mol. Cancer 2006, 5, 1-8.
61. Pouget, C.; Lauthier, F.; Simon, A.; Fagnere, C.; Basly, J.-P.; Delage, C.; Chulia, A.-J. Flavonoids: Structural requirements for antiproliferative activity on breast cancer cells. Bioorg. Med. Chem. Lett. 2001, 11, 3095-3097. (Pubitemid 33092000)
62. Cai, H.; Sale, S.; Schmid, R.; Britton, R.G.; Brown, K.; Steward, W.P.; Gescher, A.J. Flavones as colorectal cancer chemopreventive agents-Phenyl-O- methylation enhances efficacy. Cancer Prevent. Res. 2009, 2, 743-750.
63. Stoner, G.; Kaighn, M.; Reddel, R.; Resau, J.; Bowman, D.; Naito, Z.; Matsukura, N.; You, M.; Galati, A.; Harris, C. Establishment and characterization of SV40 T-antigen immortalized human esophageal epithelial cells. Cancer Res. 1991, 51, 365-371.
64. Reddel, R.R.; Ke, Y.; Gerwin, B.I.; McMenamin, M.G.; Lechner, J.F.; Su, R.T.; Brash, D.E.; Park, J.-B.; Rhim, J.S.; Harris, C.C. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res. 1988, 48, 1904-1909.
65. Bock, K.W.; Köhle, C. Ah receptor- and TCDD-mediated liver tumor promotion: Clonal selection and expansion of cells evading growth arrest and apoptosis. Biochem. Pharmacol. 2005, 69, 1403-1408. (Pubitemid 40602440)
66. Levine-Fridman, A.; Chen, L.; Elferink, C.J. Cytochrome P4501A1 promotes G1 phase cell cycle progression by controlling aryl hydrocarbon receptor activity. Mol. Pharmacol. 2004, 65, 461-469.
67. Wen, X.; Walle, T. Cytochrome P450 1B1, a biomarker and chemopreventive target for benzo[a] pyrene-initiated human esophageal cancer. Cancer Lett. 2006, 246, 109-114. (Pubitemid 44959380)
68. Ta, N.; Walle, T. Aromatase inhibition by bioavailable methylated flavones. J. Steroid Biochem. Mol. Biol. 2007, 107, 127-129. (Pubitemid 47362668)
69. Kao, Y.-C.; Zhou, C.; Sherman, M.; Laughton, C.A.; Chen, S. Molecular basis of the inhibition of human aromatase (estrogen synthetase) by flavone and isoflavone phytoestrogens: A site-directed mutagenesis study. Environ. Health Perspect. 1998, 106, 85-92. (Pubitemid 28143862)
70. Wen, X.; Walle, T. Methylation protects dietary flavonoids from rapid hepatic metabolism. Xenobiotica 2006, 36, 387-397. (Pubitemid 43879739)
71. Galati, G.; O'Brien, P.J. Potential toxicity of flavonoids and other dietary phenolics: Significance for their chemopreventive and anticancer properties. Free Rad. Biol. Med. 2004, 37, 287-303.
72. Chan, T.S.; Galati, G.; Pannala, A.S.; Rice-Evans, C.A.; O'Brien, P.J. Simultaneous detection of the antioxidant and pro-oxidant activity of dietary polyphenolics in a peroxidase system. Free Rad. Biol. Med. 2003, 37, 787-794.
73. Awad, H.M.; Boersma, M.G.; Boeren, S.; van Bladeren, P.J.; Vervoort, J.; Rietjens, I.M.C.M. Quenching of quercetin quinone/quinone methides by different thiolate scavengers: Stability and reversibility of conjugate formation. Chem. Res. Toxicol. 2003, 16, 822-831.
74. Walle, T.; Vincent, T.S.; Walle, U.K. Evidence of covalent binding of the dietary flavonoid quercetin to DNA and protein in human intestinal and hepatic cells. Biochem. Pharmacol. 2003, 65, 1603-1610.
75. van der Woude, H.; Alink, G.M.; van Rossum, B.E.J.; Walle, U.K.; van Steeg, H.; Walle, T.; Rietjens, I.M.C.M. Formation of transient covalent protein and DNA adducts by quercetin in cells with and without oxidative enzyme activity. Chem. Res. Toxicol. 2005, 18, 1907-1916.
76. Tsuji, P.A.; Walle, T. Cytotoxic effects of the dietary flavones chrysin and apigenin in a normal trout liver cell line. Chem.-Biol. Interactions 2008, 171, 37-44. (Pubitemid 350191840)
77. Goss, L.B.; Sabourin, T.D. Utilization of alternative species for toxicity testing. J. Appl. Toxicol. 1985, 5, 193-219.
78. Lee, J.-E.; Safe, S. 3′,4′-Dimethoxyflavone as an aryl hydrocarbon receptor antagonist in human breast cancer cells. Toxicol. Sci. 2000, 58, 235-242. (Pubitemid 32042422)
79. 14C] quercetin in the ACI rat. Jap. J. Exp. Med. 1983, 53, 41-50.
80. Gugler, R.; Leschik, M.; Dengler, H.J. Disposition of quercetin in man after single oral and intravenous doses. Eur. J. Clin. Pharmacol. 1975, 9, 229-234.
81. Walle, T.; Walle, U.K. Medical University of South Carolina, Charleston, SC, USA. Unpublished work, 2008.